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Coronaviruses of potential recombinant origin with por-
cine transmissible gastroenteritis virus (TGEV), referred to 
as a new subtype (IIb) of canine coronavirus (CCoV), were 
recently identiﬁ  ed in dogs in Europe. To assess the distri-
bution of the TGEV-like CCoV subtype, during 2001–2008 
we tested fecal samples from dogs with gastroenteritis. 
Of 1,172 samples, 493 (42.06%) were positive for CCoV. 
CCoV-II was found in 218 samples, and CCoV-I and CCoV-
II genotypes were found in 182. Approximately 20% of the 
samples with CCoV-II had the TGEV-like subtype; detec-
tion rates varied according to geographic origin. The highest 
and lowest rates of prevalence for CCoV-II infection were 
found in samples from Hungary and Greece (96.87% and 
3.45%, respectively). Sequence and phylogenetic analyses 
showed that the CCoV-IIb strains were related to prototype 
TGEV-like strains in the 5′ and the 3′ ends of the spike pro-
tein gene.
C
oronaviruses (CoVs) (order Nidovirales, family Coro-
naviridae) are exceptionally prone to genetic evolution 
through accumulation of point mutations in genes encod-
ing for structural and nonstructural proteins and homolo-
gous recombination among members of the same antigenic 
group (1). CoVs are organized by antigenic group. The ﬁ  rst 
group is subdivided into subgroups 1a and 1b. Subgroup 
1a includes highly related viruses (i.e., porcine transmis-
sible gastroenteritis virus [TGEV] and its derivative por-
cine respiratory coronavirus [PRCoV], feline coronavi-
ruses [FCoVs], and canine coronaviruses [CCoVs]) (2). 
According to a proposal by the Coronavirus Study Group 
of the International Committee of Taxonomy of Viruses, 
and given the virus’ close genetic relatedness (i.e., >96% aa 
identity in the key replicase 1ab domains), TGEV, FCoV, 
and CCoV should not be considered separate viruses. In-
stead, they should be considered host range variants of the 
same species (3).
CCoVs exemplify the genetic evolution and complexi-
ty of CoVs. To date, 2 CCoV genotypes are known, CCoV-I 
and CCoV-II (4); they share up to 96% of nucleotide iden-
tity in the viral genome (Lorusso et al., unpub. data) but are 
highly divergent in the spike protein gene (5). In addition, 
CCoV-I displays a novel open reading frame (ORF3) that 
encodes for a putative glycosylated protein, which is likely 
secreted from the infected cells (6). The 2 CCoV genotypes 
are commonly detected in the feces of dogs with diarrhea 
and often simultaneously infect the same dog (7). Both 
CCoV genotypes have been associated with mild clinical 
signs in pups, although hypervirulent strains have been re-
ported to cause severe, fatal enteritis (8–10); a pantropic 
variant was responsible for systemic disease in natural and 
experimental conditions (11–13).
It has been postulated that TGEV originated from 
CCoV-II through cross-species transmission, which is sup-
ported by the high genetic relatedness between the 2 virus-
es and by the presence of ORF3 remnants in CCoV-II and 
TGEV genomes (6). More recently, novel CCoV-II strains, 
which likely originated from a double recombination event 
with TGEV, occurring in the 5′ end of the spike protein 
gene, have been isolated (14,15). Accordingly, genotype 
II has been further divided into 2 subtypes, CCoV-IIa and 
CCoV-IIb, including extant and TGEV-like CCoVs, re-
spectively (14).
To assess the distribution of the TGEV-like CCoVs in 
canine populations of different geographic areas of Europe, 
we used a subtype IIb-speciﬁ  c reverse transcription–PCR 
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(RT-PCR) assay. In addition, we evaluated the genetic rela-




During 2001–2008, a total of 1,172 fecal samples 
were collected from dogs with acute enteritis in 14 Euro-
pean countries: Italy (n = 760), United Kingdom (n = 199), 
Greece (n = 81), Hungary (n = 41), Portugal (n = 33), Spain 
(n = 32), Belgium (n = 7), Romania (n = 6), Bulgaria (n 
= 3), Germany (n = 3), Sweden (n = 3), Slovakia (n = 2), 
Poland (n = 1), and Slovenia (n = 1). Some samples were 
retrieved from previous studies (7,16–18), whereas the re-
maining samples were sent to our laboratory (from veteri-
narians, breeders, or other researchers) for routine diagnos-
tic investigations.
RNA Extraction
Specimens were homogenized (10% wt/vol) in Dul-
becco modiﬁ  ed Eagle medium and subsequently clariﬁ  ed 
by centrifuging at 2,500 × g for 10 min. For RNA extrac-
tion, 140 μL of the supernatants were then used by means 
of QIAamp Viral RNA Mini Kit (QIAGEN S.p.A., Milan, 
Italy); according to the manufacturer’s protocol, RNA tem-
plates were stored at –70°C until use.
CCoV RNA Detection, Quantiﬁ  cation, and Genotyping
For rapid detection and quantiﬁ  cation of CCoV RNA, 
all RNA extracts were subjected to a previously established 
TaqMan-based real-time RT-PCR (16) with minor modiﬁ  -
cations. Brieﬂ  y, a 1-step method was adopted by using the 
Platinum Quantitative PCR ThermoScript One-Step System 
(Invitrogen S.R.L., Milan, Italy) and the following 50-μL 
mixture: 25 μL of master mix, 300 nM of primers CCoV-for-
ward (5′-TTGATCGTTTTTATAACGGTTCTACAA-3′) 
and CCoV-reverse (5′-AATGGGCCATAATAGCCA
CATAAT-3′), 200 nM of probe CCoV-Pb (5′-FAM-
ACCTCAATTTAGCTGGTTCGTGTATGGCATT-
BHQ1-3′), and 10 μL of template RNA. To obtain a stan-
dard curve for absolute quantiﬁ  cation, we simultaneously 
analyzed duplicates of log10 dilutions of standard RNA 
(16). The thermal proﬁ  le consisted of reverse transcription 
at 50°C for 20 min, activation of Platinum Taq DNA poly-
merase at 95°C for 2 min, 45 cycles of denaturation at 95°C 
for 15 s, annealing at 48°C for 30 s, and extension at 60°C 
for 30 s.
The positive samples were characterized by 2 dis-
tinct genotype-speciﬁ   c assays (17) performed by using 
the Platinum Quantitative PCR ThermoScript One-Step 
System (Invitrogen S.R.L.) and the following oligonucle-
otide sets (ﬁ  nal concentrations were 600 and 200 nM for 
primers and probes, respectively): primer pair CCoVI-F 
(5′-CGTTAGTGCACTTGGAAGAAGCT-3′)/CCoVI-R 
(5′-ACCAGCCATTTTAAATCCTTCA-3′) and probe 
CCoVI-Pb (5′-FAM-CCTCTTGAAGGTACACCAA-
TAMRA-3′) for CCoV-I; primer pair CCoVII-F (5′-
TAGTGCATTAGGAAGAAGCT-3′)/CCoVII-R (5′-AGC
AATTTTGAACCCTTC-3′) and probe CCoVII-Pb (5′-FAM 
-CCTCTTGAAGGTGTGCC-TAMRA-3′) for CCoV-II. 
The thermal protocol was as described for CCoV detection 
except for different annealing temperatures (i.e., 53°C and 
48°C for CCoV-I and CCoV-II, respectively).
Development of RT-PCRs Speciﬁ  c for 
Classical and TGEV-like CCoVs
Considering the high divergence observed in the 5′ end 
of the spike gene between classical (subtype IIa) and TGEV-
like (subtype IIb) CCoVs, speciﬁ  c CCoV-IIa and CCoV-IIb 
gel-based RT-PCRs were developed. Primer 20179 (sense, 
5′-GGCTCTATCACATAACTCAGTCCTAG-3′) binds a 
conserved region at the 3′ end of ORF1b and was recruit-
ed from a previous study (13), whereas antisense primers 
INS-R-dg (5′-GCTGTAACATAKTCRTCATTCCAC-3′) 
and 174-268 (5′-CAACATGTAACCTTTGTCTGTGATC
TGC-3′) target regions at the 5′ end of the spike protein 
gene of feline CoV-II (FCoV-II)/classical CCoV-II and 
TGEV/TGEV-like CCoV, respectively. Separate RT-PCRs 
with primers 20179/INS-R (CCoV-IIa) or 20179/174-268 
(CCoV-IIb) were conducted by using SuperScript One-
Step RT-PCR for Long Templates (Invitrogen S.R.L.), ac-
cording to the manufacturer’s instructions. The following 
thermal protocol was used: reverse transcription at 50°C 
for 30 min, inactivation of Superscript II RT at 94°C for 2 
min, 40 cycles of 94°C for 30 s, 55°C for 30 s, 68°C for 30 
s, and ﬁ  nal extension at 68°C for 10 min. The PCR prod-
ucts were detected by using electrophoresis through a 1.5% 
agarose gel and examination under UV light after ethidium 
bromide staining.
RT-PCR for Ampliﬁ  cation of the 3′ End 
of the Spike Protein Gene of CCoV-II
To rule out any potential infection by true TGEV 
strains and to conﬁ  rm the recombinant origin of the TGEV-
like CCoVs, we submitted 20 samples that were positive 
for CCoV-IIb and negative for CCoV-I to RT-PCR ampli-
ﬁ  cation of the 3′ end of the spike protein gene of CCoV-II 
(7). Primers S5 (5′-TGCATTTGTGTCTCAGACTT-3′) 
and S6 (5′-CCAAGGCCATTTTACATAAG-3′) were used 
in the RT-PCR, performed according to the protocol de-
scribed for CCoV subtyping.
RT-PCR of the ORF7a/7b Region
To rule out the presence of true TGEV strains in 
the dog feces that were positive by CCoV-IIb–specif-
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ic assay, we used an RT-PCR that had been proven 
to discriminate between TGEV and CCoV on the ba-
sis of amplicon size (19). In fact, primers N3SN (5′-
GTGTTTGATGACACACAGGTTGAG-3′) and R3AS (5′-
GCTTACCATTCTGTACAAGAGGTAG-3′) target the 3′ 
end of the viral genome, where CCoV/FCoV and TGEV 
display 2 (ORFs 7a and 7b) and 1 (ORF7) accessory genes, 
respectively. As controls, the following reference group-
1a CoVs were used: TGEV-Purdue (kindly provided by 
P. Cordioli, Istituto Zooproﬁ  lattico Sperimentale di Lom-
bardia ed Emilia Romagna, Brescia, Italy), FCoV-I-249/04 
(20), FCoV-II-29/92 (21), CCoV-I-Elmo/02 (5), CCoV-IIa-
CB/05 (11), CCoV-IIb-341/05, CCoV-IIb-174/06, CCoV-
IIb-430/07, and CCoV-IIb-119/08 (14).
Sequence and Phylogenic Analyses
The RT-PCR products obtained with primer pairs 
20179/174-268 and S5/S6 from 26 samples having posi-
tive CCoV-IIb–speciﬁ  c assay results and representative of 
the different geographic areas were subjected to direct se-
quencing at the BaseClear B.V. (Leiden, the Netherlands). 
The sequences were manually edited and analyzed by using 
BioEdit software (22) and National Center for Biotechnol-
ogy Information (www.ncbi.nlm.nih.gov) and European 
Molecular Biology Laboratory (www.ebi.ac.uk) analysis 
tools. Phylogenetic and molecular evolutionary analyses 
were conducted by using Mega 4.1, beta (23). Phylogenetic 
trees on the basis of partial 5′ (339-nt) and 3′ (520-nt) ends 
of the spike protein gene were elaborated by using parsi-
mony and neighbor-joining methods, which supplied statis-
tical support with bootstrapping >1,000 replicates. Group-2 
CoV canine respiratory CoV-240/05 (24) was used as an 
outgroup. The nucleotide sequences of the analyzed CCoV-
IIb strains were deposited in GenBank under accession nos. 
GQ130243–GQ130268 and GQ148749–GQ148774 for 5′ 
and 3′ ends of the spike gene, respectively.
Results
CCoV Detection and Quantiﬁ  cation
CCoV RNA was detected in 493 (42.06%) of 1,172 
fecal samples from dogs with diarrhea. Viral RNA titers 
ranged from 1.25 × 101 to 7.56 × 107 copies/μL of template. 
For each geographic region of origin, detection rates of the 
CCoV real-time RT-PCR were Italy 330/760 (43.42%), 
United Kingdom 54/199 (27.13%), Greece 45/81 (55.5%), 
Hungary 32/42 (78.05%), Portugal 12/33 (36.36%), Spain 
2/32 (6.25%), Belgium 4/7 (57.14), Romania 4/6 (66.66%), 
Bulgaria 1/3 (33.33%), Germany 3/3 (100%), Sweden 3/3 
(100%), Slovakia 1/2 (50%), Poland 1/1 (100%), and Slo-
venia 1/1 (100%) (Table 1).
CCoV Genotype and Subtype Distribution
The geographic distribution of the CCoV types and sub-
types is reported in Table 1. Genotype-speciﬁ  c ampliﬁ  ca-
tion assays showed that 93 (18.86%) of 493 CCoV-positive 
samples were positive for CCoV-I, and 218 (44.22%) were 
positive for CCoV-II. In addition, 182 samples (36.92%) 
were positive for both genotypes. Both genotypes were 
found to circulate in most European countries that had been 
sampled, and an overall prevalence of CCoV-II was found 
in all countries except Greece, where the 2 genotypes were 
detected approximately to the same extent.
By using the developed TGEV-like RT-PCR, we 
found that 78 (19.50%) of 400 samples containing CCoV-
II strains, alone or in combination with CCoV-I, were 
positive for CCoV-IIb. The remaining 322 CCoV-II strains 
were positive for subtype IIa, whereas mixed infections 
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Table 1. Distribution of CCoV genotypes and TGEV-like strains (CCoV-IIb) in dogs in European countries, 2001–2008* 
No. or % positive 
Country
No.
samples CCoV, no.  CCoV-I no.† CCoV-II, no.† CCoV-I+II, no.‡ CCoV-IIb, no. CCoV-IIb/II, %
Italy 760 330 54 138 138 34 12.32
United Kingdom 199 54 13 24 17 10 24.39
Greece 81 45 16 15 14 1 3.45
Hungary 41 32 0 30 2 31 96.87
Portugal 33 12 6 3 3 0 0
Spain 32 2 0 1 1 0 0
Belgium 7 4 1 3 0 0 0
Romania 6 4 1 1 2 1 33.33
Bulgaria 3 1 0 1 0 0 0
Germany 3 3 0 0 3 0 0
Sweden 3 3 1 1 1 1 50
Slovakia 2 1 0 0 1 0 0
Poland 1 1 0 1 0 0 0
Slovenia 1 1 1 0 0 0 0
Total 1,172 493 93 218 182 78 19.50
*CCoV, canine coronavirus; TGEV, porcine transmissible gastroenteritis virus.  
†Infections with a single CCoV genotype. 
‡Infections with both CCoV genotypes. RESEARCH
caused by both CCoV-II subtypes were not detected in 
any samples. Almost all CCoV–IIb-positive samples were 
from Italy (34/276; 12.32%), the United Kingdom (10/41; 
24.39%), and Hungary (31/32; 96.87%). Single CCoV-
IIb strains were detected in samples from Greece (1/29; 
3.45%), Romania (1/3; 33.33%), and Sweden (1/2; 50%), 
whereas no samples from the other countries had TGEV-
like CCoVs.
RT-PCR of ORF7a/7b Region
After RT-PCR with primer pair N3SN/R3AS, CCoV 
and FCoV reference strains yielded an amplicon >1,000 
bp, with the exception of TGEV-like CCoV 341/05, which 
gave a 929-bp product as a consequence of a 154-nt de-
letion in ORF7b (14). In contrast, a 367-bp product was 
obtained from TGEV-Purdue, as previously described (19). 
This pattern of ampliﬁ  cation agreed with the absence of 
ORF7b in TGEV (25). All 20 samples that were positive 
according to the CCoV-IIb–speciﬁ  c assay and negative ac-
cording to the CCoV-I TaqMan assay were conﬁ  rmed to 
contain true CCoV strains because they yielded RT-PCR 
products considerably larger than the 367-bp amplicon ob-
tained from TGEV.
Sequence and Phylogenetic Analyses
We selected the following TGEV-like strains for se-
quence analysis of the 5′ and 3′ ends of the spike protein 
gene: 12 strains from Italy, 8 from the United Kingdom, 
and 5 from Hungary, plus the single strains from Greece, 
Romania, and Sweden. All RT-PCR products were se-
quenced except those obtained from the samples from 
Greece and Sweden, which yielded weak bands despite the 
considerable viral RNA titers in the original fecal samples 
(5.02 × 104 and 5.76 × 106 RNA copies/μL of template, 
respectively).
The obtained sequences were compared with each oth-
er (Table 2) and with 3 CCoV-IIa, 4 CCoV-IIb, 2 FCoV-
II, 2 CCoV-I, 3 FCoV-I, and 3 TGEV reference sequences 
(Table 3). Sequence comparison of the TGEV-like strains 
showed overall nucleotide identity of 83.6%–99.6% and 
92.7%–100% in the 5′ and 3′ ends of the spike gene, re-
spectively. By analyzing the TGEV-like strains by country 
of origin, we found the highest genetic variability among 
the viruses from Italy (86.8%–99.3% and 94.5%–99.8% of 
nucleotide identity in the gene 5′ and 3′ ends, respectively), 
whereas the strains from Hungary showed the highest re-
latedness (92.7%–99.3% and 98.4%–99.6% of nucleotide 
identity in the gene 5′ and 3′ ends, respectively) (Table 2). 
The TGEV-like strains exhibited the best identity to proto-
type strains (14) in both the 5′ (85.9%–99.3%) and the 3′ 
end (92.7%–99.8%) of the spike gene, whereas a slightly 
lower identity was found to the old strain UCD1 (19) in 
the 5′ end, which is the only sequence available in the Gen-
Bank database. When the 5′ end was analyzed, the identiﬁ  ed 
TGEV-like CCoVs were more related to classical TGEVs 
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Table 2. Percent nucleotide identities in the 5ƍ (top right) and 3ƍ (bottom left) ends of the spike gene of CCoV-IIb (TGEV-like) strains 
from dogs in Europe, 2001–2008* 
Country  Italy  United Kingdom  Hungary  Romania  Overall 
Italy  86.8–99.3 
94.5–99.8 
83.6–92.7  86.5–99.0  89.1–99.3  83.6–99.3 
United Kingdom  92.7–97.0  88.5–99.6 
97.6–99.8 
87.8–97.0  87.8–93.1  83.6–99.6 
Hungary  94.7–100  92.9–94.9  92.7–99.3 
98.4–99.6 
94.7–99.3  86.5–99.3 
Romania  95.3–99.6  93.5–94.5  98.6–99.6  ND  87.8–99.3 
Overall  92.7–100  92.7–99.8  92.9–100  93.5–99.6  83.6–99.6 
92.7–100 
*CCoV, canine coronavirus; TGEV, porcine transmissible gastroenteritis virus; ND, not done because only a single strain from Romania was analyzed.  
Table 3. Percent nucleotide identity of representative TGEV-like 
CCoVs to group-1a CoV reference strains in the 5ƍ and 3ƍ ends of 




accession no. 5ƍ end†  3ƍ end‡ 
CCoV-IIb-341/05  EU856361  88.1–99.3  94.7–99.4 
CCoV-IIb-174/06  EU856362  86.8–99.0  93.3–97.0 
CCoV-IIb-430/07  EU924790  85.9–97.3  92.7–97.0 
CCoV-IIb-119/08  EU924791  89.1–99.0  93.7–99.8 
CCoV-IIb-UCD1  AF116248  76.6–85.7  NA 
TGEV-Purdue  NC_002306  76.6–84.4  91.4–93.1 
TGEV-TS  DQ201447  76.2–84.4  90.8–92.5 
TGEV-96-1933  AF104420  74.0–81.8  87.1–88.8 
PRCoV-RM4  Z24675  NA  90.2–91.6 
PRCoV-86-137004  X60089  NA  90.2–91.6 
CCoV-IIa-Insavc-1  D13096  35.4–38.3  92.1–95.3 
CCoV-IIa-CB/05  DQ112226  35.1–37.7  93.7–99.0 
CCoV-IIa-BGF10  AY342160  34.2–37.5  90.8–94.3 
FCoV-II-79-1146  NC_007025  34.0–36.6  90.2–91.6 
FCoV-II-79-1683  X80799  34.6–37.5  90.4–91.9 
CCoV-I-Elmo/02  AY307020  37.6–40.4  61.8–62.8 
CCoV-I-23/03  AY307021 31.8–34.8  60.3–61.2 
FCoV-I-KU-2  D32044  37.4–40.8  59.1–60.3 
FCoV-I-Black  EU186072  36.2–39.3  58.9–61.0 
FCoV-I-UCD1  AB088222  38.3–42.7  57.9–58.9 
*TGEV, porcine transmissible gastroenteritis virus; CCoV, canine 
coronavirus; NA, sequence not available. 
†Nucleotides 1–305 of the spike gene of reference strain CCoV-IIb-
341/05.  
‡Nucleotides 3574–4085 of the spike gene of reference strain CCoV-IIb-
341/05.  Recombinant Canine Coronaviruses in Dogs, Europe
(76.6%–84.4%) than to type IIa CCoVs (34.2%–38.3%). 
In contrast, analysis of the 3′ end of the spike gene showed 
nucleotide identities of 87.1%–93.1% to TGEV and of 
90.8%–99.0% to CCoV-IIa. The best identities among 
CCoV-IIa isolates were to strain Insavc-1, which has been 
proposed as intermediate virus between CCoV and TGEV 
(26) and to the more recent pantropic strain CB/05 (11) in 
the 5′ and 3′ ends, respectively.
At the phylogenetic level, the sequenced strains were 
grouped in the same cluster with TGEV and prototype 
CCoV-IIb strains at the 5′ end of the spike protein gene, 
displaying an obvious distance to both CCoV-IIa/FCoV-
II and CCoV-I/FCoV-I (Figure, panel A). The TGEV-like 
CCoVs from the United Kingdom formed a unique clade, 
whereas the strains detected in eastern Europe were mixed 
with CCoV-IIb viruses from Italy. The old TGEV-like 
  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 16, No. 1, January 2010  45 
Figure. Phylogenetic analysis of canine coronavirus (CCoV) type IIb. Maximum parsimony trees based on partial 5′ (A) and 3′ (B) ends 
of the spike protein gene of group-1a coronaviruses (CoVs). For phylogenetic tree construction, the following reference strains were 
used (GenBank accession numbers are in parentheses): porcine transmissible gastroenteritis virus (TGEV) Purdue (NC_002306), TS 
(DQ201447), 96-1933 (AF104420), porcine respiratory coronavirus (PRCoV, only 3′ end) RM-4 (Z24675), 86-137004 (X60089), CCoV-IIa 
CB/05 (DQ112226), Insavc-1 (D13096), BGF10 (AY342160), CCoV-IIb 341/05 (EU856361), 174/06 (EU856362), 430/07 (EU924790), 
118/08 (EU924791), UCD-1 (AF116248, only 5′ end), CCoV-I Elmo/02 (AY307020), 23/03 (AY307021), feline coronavirus (FCoV) type 
I Black (EU186072), KU-1 (D32044), UCD-1 (AB088222), FCoV-II 79-1146 (NC_007025), 79-1183 (X80799). The tree is rooted on the 
group-2 CoV canine respiratory coronavirus (CRCoV) 240/05 (EU999954). Statistical support was provided by bootstrapping >1,000 
replicates. Scale bars indicate estimated numbers of nucleotide substitutions per site.RESEARCH
strain, UCD1, clustered with TGEV isolates. At the 3′ end 
of the same gene, subtype IIa and IIb strains segregated to-
gether and were separated from the FCoVs and the porcine 
CoVs TGEV and PRCoV (Figure, panel B). In addition, the 
strains from the United Kingdom were again grouped in a 
separate subcluster.
Discussion
CoVs are exceptionally prone to variability through ac-
cumulation of point mutations and recombination events. A 
CCoV strain displaying close relatedness to porcine CoVs 
in the N-terminus of the spike protein, which is related to 
porcine CoVs, was isolated ≈20 years ago, but the subse-
quent molecular characterization was restricted to the 5′ end 
of the spike gene (19). Additional TGEV-like CCoVs were 
reported more recently in Italy (14) and the United King-
dom (15). However, full biological and molecular charac-
terization was carried out only for the isolates from Italy, 
showing that the TGEV-like strains are likely recombinant 
with TGEV at the level of the 5′ end of the spike gene (14). 
Experimental infection of CCoV-seronegative beagle pups 
showed that TGEV-like (i.e., subtype IIb) CCoV induces 
clinical signs resembling those of classical (i.e., subtype 
IIa) CCoVs, that is, mild diarrhea for a few days. (14) Un-
like pantropic CCoV (11–13), TGEV-like CCoV was not 
able to spread systemically. Of the 4 recombinant strains 
detected in Italy, 2 had originated from eastern Europe, but 
at the phylogenetic level they were mixed with strains from 
Italy. The prevalence of this CCoV subtype in the canine 
population has not been determined in previous studies.
Our epidemiologic investigation assessed the distri-
bution of CCoV-IIb in the dog population of Europe. Ap-
proximately 50% of the analyzed samples were positive 
for CCoV, showing the presence of CCoV-I or CCoV-II. 
Mixed infections caused by both genotypes were detect-
ed in <40% of the CCoV-positive samples, considerably 
lower than previously reported percentages (7,17). Ap-
proximately 20% of the CCoV–II-positive samples con-
tained TGEV-like strains (Table 1). However, the preva-
lence of this CCoV subtype differed by geographic origin 
of the samples; the highest detection rates (96.87%) were 
observed in Hungary. The recombinant origin of all strains 
characterized by RT-PCR was conﬁ  rmed by sequence anal-
ysis of 5′ and 3′ ends of the spike gene and by RT-PCR of 
the ORF7a/7b region. The selected 26 TGEV-like strains 
were related to prototype strains from Italy (14) in both the 
5′ and the 3′ ends of the spike gene. A comparison with 
the prototype UK strains reported by Erles and Brownlie 
(15) was not possible, however, because the unique spike 
sequence deposited in the GenBank is located more down-
stream of the gene with respect to the sequences that we 
obtained.
On the basis of the spike gene sequences, the strains 
from Italy and eastern Europe were closely related, whereas 
the strains from the United Kingdom were more genetically 
distant (Table 3). This pattern of segregation was conﬁ  rmed 
by phylogenic analysis, which showed that viruses detect-
ed in the United Kingdom formed a separate cluster with 
respect to the samples from Italy, Hungary, and Romania 
(Figure). The genetic relatedness between the TGEV-like 
strains from Italy and those from eastern Europe may be 
accounted for by extensive dog importation to Italy. In ad-
dition, dog exchange between eastern Europe and Italy has 
been associated with the reemergence of canine infectious 
hepatitis (27) and the spread of the arctic lineage of canine 
distemper virus (28).
In the 5′ end of the spike gene, the old TGEV-like 
strain, UCD1, was found to be genetically more related to 
true TGEV isolates than to recent CCoV-IIb strains, there-
by accounting for recombination events occurring at dif-
ferent times. With the exception of strain UCD1, analysis 
of archival samples found the oldest TGEV-like strain in 
2001, about 4 years before this CCoV subtype was reported 
in Italy (14).
Our study conﬁ  rms that recombinant CCoVs are effec-
tively circulating in dogs in different European countries. 
Considering the genetic distance in the spike protein, this 
circulation questions the efﬁ  cacy of vaccines, which are 
based on classical (CCoV-IIa) strains, against the emerging 
TGEV-like (CCoV-IIb) viruses. Only vaccination trials and 
subsequent challenges by TGEV-like strains might assess 
whether the poor cross-reactivity between CCoV-IIa and 
CCoV-IIb observed in a previous study (14) might affect the 
immune response of dogs against the recombinant viruses.
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